I have received one as well, and I am quite new although have been monitoring Tis for years.
Regulatory approval is a key risk for most bio stocks. EMA is likely to be easy to approve but takes longer time. I recalled PXS Bronchitol finally got approval in EU but took few fights as well. This time Tis may get approval, touch wood!
GLTA